Galera Therapeutics, Inc. | LinkedIn
Galera Therapeutics, Inc. Approves Reduction in the Company's Current Workforce by 22 Employees, or Approximately 70% of the Company's Headcount -August 10, 2023 at 08:01 am EDT | MarketScreener
Galera Therapeutics, Inc. - SEC Filing
Galera Therapeutics: Reasonable Valuation With Fast Track And Breakthrough Designation (NASDAQ:GRTX) | Seeking Alpha
In this photo illustration, the Galera Therapeutics, Inc. logo is displayed on a smartphone screen. (Photo by Rafael Henrique / SOPA Images/Sipa USA Stock Photo - Alamy
Galera Therapeutics, Inc. - Investors
Galera Therapeutics Inc. (@GaleraTx) / X
Galera Therapeutics Company Profile: Stock Performance & Earnings | PitchBook
Transforming Radiotherapy for Patients with Cancer - Galera Therapeutics, Inc.
Galera Therapeutics, Inc. | LinkedIn
Galera Therapeutics Inc. (@GaleraTx) / X
GRTX Insider Trading Activity - Galera Therapeutics Inc.
Why is Galera Therapeutics' stock soaring? GRTX up over 150% | Kalkine Media
January 16, 2023, Brazil. in this Photo Illustration, the Galera Therapeutics, Inc Editorial Photo - Image of financial, online: 266588126
Galera Therapeutics (NASDAQ: GRTX) implodes 80% on FDA decision against company
GRTX - Galera Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGM)
Galera Therapeutics Inc.: Stock Market News and Information
Galera Therapeutics Inc Share Price USD0.001
Galera Therapeutics: Trial Reversal Did Not Take The Stock Higher (NASDAQ:GRTX) | Seeking Alpha
Galera Therapeutics Inc. (@GaleraTx) / X
Galera Therapeutics Inc. (@GaleraTx) / X
Galera Therapeutics Inc. (@GaleraTx) / X
Galera Therapeutics (NASDAQ:GRTX) Stock Price News
Galera's big-money drug has roots in Monsanto lab
CFO of the Year Awards 2020: Chris Degnan, Galera Therapeutics Inc. - Philadelphia Business Journal
Transforming Radiotherapy for Patients with Cancer - Galera Therapeutics, Inc.
